Prostaglandin F2α stimulates PI3K/ERK/mTOR signaling and skeletal myotube hypertrophy

Mitogen-activated protein kinase signaling is necessary for the maintenance of skeletal muscle mass

(2009) Hao Shi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

COX-2 inhibitor reduces skeletal muscle hypertrophy in mice

(2009) Margaret L Novak et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Form and flexibility in phosphoinositide 3-kinases

(2009) Roger Williams et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Inhibition of mammalian target of rapamycin (mTOR) signalling in C2C12 myoblasts prevents myogenic differentiation without affecting the hyperphosphorylation of 4E-BP1

(2009) Mark Willett et al.   CELLULAR SIGNALLING

Role of IGF-I in skeletal muscle mass maintenance

(2009) David R. Clemmons   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Amino acid regulation of TOR complex 1

(2008) Joseph Avruch et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Prostaglandin F2α promotes muscle cell survival and growth through upregulation of the inhibitor of apoptosis protein BRUCE

(2008) K M Jansen et al.   CELL DEATH AND DIFFERENTIATION

Signal transduction pathways that regulate muscle growth

(2008) Henning Wackerhage et al.   Essays in Biochemistry

TNF-α increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK

(2007) Isabelle Plaisance et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

PGF2α-associated vascular smooth muscle hypertrophy is ROS dependent and involves the activation of mTOR, p70S6k, and PTEN

(2007) K.M. Rice et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS